London's DeepVerge Passes Trials

DeepVerge announces successful completion of its trial on its wastewater Covid-19 detection technology.

03:41 28 June 2021

DeepVerge has announced the successful completion of its wastewater Covid-19 detection technology last week. The news has caused the London-listed scientific research group's shares to jump to 34.5p per share or 7.81per cent. 

 

The technology, known as Microtox, uses artificial intelligence to predict the potential growth of clusters of the Covid-19 virus - or any other dangerous pathogen in the future. It could act as an early warning system for outbreaks of the disease. The system will be installed and maintained by compliance testing services group EPS. 

 

CEO Gerard Brandon said: “By establishing a permanent anonymised mass surveillance of wastewater, DeepVerge claims a world-first real-time defence against this global pandemic,” 

 

“The installation of Microtox wastewater units will enable live data to simultaneously identify the source of Covid-19 cases as well as identify Covid-19 clusters with the ability to indicate the size of each cluster.”

 

DeepVerge has previously closed a deal with China Resources to form a joint venture for the manufacture and sale of environmental monitoring equipment. 

 

“We expect updates from our Joint Venture agreement with China Resources and roll-out in the US to follow early in Q3,” the CEO said.